Juan Luis
García Hernández
Publicaciones en las que colabora con Juan Luis García Hernández (44)
2016
-
Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse
Oncotarget, Vol. 7, Núm. 49, pp. 80664-80679
-
Post-transcriptional modifications contribute to the upregulation of cyclin D2 in multiple myeloma
Clinical Cancer Research, Vol. 22, Núm. 1, pp. 207-217
2015
-
MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
BMC Cancer, Vol. 15, Núm. 1
2013
-
Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes
Leukemia, Vol. 27, Núm. 3, pp. 610-618
2012
-
Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling
Annals of Oncology, Vol. 23, Núm. 8, pp. 2138-2146
-
Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression
Pharmacogenetics and Genomics, Vol. 22, Núm. 5, pp. 381-388
-
Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement
European Journal of Haematology, Vol. 89, Núm. 1, pp. 37-41
-
Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme
Annals of Surgical Oncology, Vol. 19, Núm. 7, pp. 2367-2379
-
Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
PLoS ONE, Vol. 7, Núm. 11
-
Response to imatinib mesylate in patients with hypereosinophilic syndrome
International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326
2011
-
Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas
PLoS ONE, Vol. 6, Núm. 9
2010
-
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma
European Journal of Haematology, Vol. 84, Núm. 4, pp. 359-361
2009
-
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas
Cancer, Vol. 115, Núm. 16, pp. 3728-3737
-
Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response
Leukemia Research, Vol. 33, Núm. 1, pp. 170-173
-
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
Leukemia, Vol. 23, Núm. 8, pp. 1515-1527
2008
-
Transient t(11;17)(q14;q12) in patient with chronic myelogenous leukemia in complete molecular response
Cancer Genetics and Cytogenetics
2006
-
Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain
Leukemia Research, Vol. 30, Núm. 8, pp. 943-948
-
Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q
British Journal of Haematology, Vol. 133, Núm. 6, pp. 642-645
2005
-
Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia
Leukemia, Vol. 19, Núm. 3, pp. 402-409
-
Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11
Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 68-72